Regular Article
Clinical Applications of Magnetic Drug Targeting

https://doi.org/10.1006/jsre.2000.6030Get rights and content

Abstract

Cancer patients often present with localized disease. Yet, surgical eradication or radiation treatment is not always possible or meaningful. Site-directed drug targeting is one way of local or regional antitumor treatment. Magnetically controlled drug targeting is one of the various possibilities of drug targeting. This technology is based on binding established anticancer drugs with ferrofluids that concentrate the drug in the area of interest (tumor site) by means of magnetic fields. Then, the drug desorbs from the ferrofluid and enfolds its mechanism of action. This paper gives the reader an overview of current applications of ferrofluids (magnetic liquids) in conjunction with magnetic fields as they relate to the latest advances in medical applications and in particular to anticancer treatment.

References (43)

  • M.A. Hofmann et al.

    Annual variations in the vasopressin neuron population of the human suprachiasmatic nucleus

    Neuroscience

    (1993)
  • R.L. Schilsky et al.

    Principles of Antineoplastic Drug Development and Pharmacology

    (1996)
  • E. Wielgus-Serafinska et al.

    Circadian variation of mitrochondrial succinic dehydrogenase and microsomal cytochrome P-450 dependent monooxygenase activity in the liver of sexually immature and mature rats

    J. Physiol. Pharmacol.

    (1993)
  • R. Senie et al.

    Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival

    Ann. Intern. Med.

    (1991)
  • B. Bruguerolle

    Circadian phase dependent pharmacokinetics of disopyramide

    Chronobiol. Int.

    (1984)
  • H.V. Ratajczak et al.

    Estrous influence on surgical cure of a mouse breast cancer

    J. Exp. Med.

    (1988)
  • Meyer, K. Season and cycle: Variation in presentation and response to therapy in premenopausal breast cancer. In 77th...
  • J.M. Waterhouse et al.

    Temporal aspects of renal drug elimination

  • R. Smaaland et al.

    Glutathione content in human bone marrow and circadian stage relation to DNA synthesis

    J. Natl. Cancer Inst.

    (1991)
  • A. Reinberg et al.

    Circadian changes of drug disposition in man

    Clin. Pharmacokinet.

    (1982)
  • R.T.W.L. Conroy et al.

    Human Circadian Rhythms

    (1970)
  • Cited by (0)

    View full text